Dapagliflozin
Dapagliflozin is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity.
| Catalog Number | T2389 |
| Alternative Name(s) | BMS-512148 |
| Research Area | GPCR/G Protein|||Angiogenesis|||Chromatin/Epigenetic |
| Molecular Formula | C21H25ClO6 |
| CAS# | 461432-26-8 |
| Purity | 99.74% |
| SMILES | CCOc1ccc(cc1)Cc1c(ccc(c1)[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)Cl |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Dapagliflozin |
| Additional Information | https://www.targetmol.com/datasheet/T2389 |